08.06.25 -- Why Is Hep C Still On The Rise? And What Atea Is Doing About It

Before you dive into clinical trials, ask yourself: Is my company operationally ready to handle the complexity that’s coming?

Selecting a CRO with deep oncology expertise and seamless trial experience is vital to navigate these complexities and deliver transformative therapies to patients faster.

Explore the common misconceptions surrounding reconsent, as well as the reality of its ability to be a flexible, ethics-driven communication practice grounded in respect for participant autonomy.

Adaptive platform trials (APTs) are reshaping clinical research by enabling multiple therapies to be tested simultaneously under a single, flexible protocol.

The U.S. has the highest maternal mortality rate among industrialized nations. For Black women, the odds are even worse. Here's why — and what can be done.

Cell and gene therapy clinical trials require adaptive regulatory and operational strategies to address complex challenges, streamline patient engagement, and support successful development and delivery.

A large European pharmaceutical company sought to benchmark a CRO’s suggestions involving a Phase III trial for a newly acquired asset.

Digital health technologies are transforming clinical trials through decentralization, improved data, and patient-centric approaches, driving efficiency and accessibility.

When considering the clinical trial criteria, take the time to review how a fully decentralized approach using mobile research nurses could help advance your next drug development study.